Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized treatment modalities for patients with relapsed/refractory hematologic cancers.1 As CAR-T therapy becomes more widely applied, toxic effects unique to CAR-T treatment are being identified that may potentially affect any organ or system.2 We report a case of a cutaneous toxic reaction after CAR-T therapy.